FP7 takes off

The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on 1 January.

The programme cleared its final hurdle when it was adopted by the Council on 18 December 2006. The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

With a total budget of €50.521 billion, FP7 will run for of seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years. EU Science and Research Commissioner Janez Potocnik hailed the FP7's approval as 'great day' for European Science. 'In financial terms, this is a major improvement over the last framework programme. In real terms, there are 40 per cent more funds on average per year,' he said.

FP7 will aim to build on the accomplishments of the previous research framework programme, and will be implemented through four specific programmes. The 'Cooperation' programme will support research cooperation in a number of key thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will fund the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

Featuring simpler instruments and streamlined procedures for funding and participation, FP7 should facilitate the greater participation by and cooperation between universities, research centres, small and medium sized enterprises (SMEs) and companies on a broad range of research areas. In doing so, the new programme should make headway on the goal of creating a European Research Area (ERA) - the equivalent of a 'common market' for research - to become the world's leading research area.

Under FP7, the highest portion of the budget will go to information and communication technologies (€9.11 billion), followed by health (€6.05 billion), transport (€4.18 billion) and nanotechnology (€3.5 billion), energy (€2.3 billion), and food, agriculture and biotechnology (€1.935 billion). Other budget lines include environmental research (€1.8 billion), space (€1.43 billion), security (€1.35 billion), and social-economic sciences and humanities (€610 million).

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...